Home Amgen, Cytokinetics Heart Failure Drug Succeeds In Mid-Stage Study
 

Keywords :   


Amgen, Cytokinetics Heart Failure Drug Succeeds In Mid-Stage Study

2015-10-28 08:39:05| Biotech - Topix.net

Amgen Inc and Cytokinetics Inc said on Tuesday their experimental drug for chronic heart failure showed significant improvement in cardiac function in the second part of a mid-stage study. The 448 patients in the trial were given an oral formulation of the drug omecamtiv mecarbil for 20 weeks and observed for 24 weeks, the companies said in a joint statement.

Tags: study heart drug failure

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
More »